These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1165 related items for PubMed ID: 24140257

  • 1. Photodynamic therapy for polypoidal choroidal vasculopathy.
    Nowak-Sliwinska P, van den Bergh H, Sickenberg M, Koh AH.
    Prog Retin Eye Res; 2013 Nov; 37():182-99. PubMed ID: 24140257
    [Abstract] [Full Text] [Related]

  • 2. [Polypoidal choroidal vasculopathy].
    Yuzawa M.
    Nippon Ganka Gakkai Zasshi; 2012 Mar; 116(3):200-31; discussion 232. PubMed ID: 22568102
    [Abstract] [Full Text] [Related]

  • 3. Long-term efficacy and safety of verteporfin photodynamic therapy in combination with anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy.
    Jain P, Anantharaman G, Gopalakrishnan M, Goyal A.
    Indian J Ophthalmol; 2018 Aug; 66(8):1119-1127. PubMed ID: 30038155
    [Abstract] [Full Text] [Related]

  • 4. Complete regression of branching vascular network in polypoidal choroidal vasculopathy by ranibizumab and photodynamic therapy, two case reports.
    Iesato Y, Tanaka M, Murata M, Kitahara J, Hirano T, Kurenuma T, Yoshida N, Murata T.
    BMC Ophthalmol; 2018 Nov 03; 18(1):284. PubMed ID: 30390650
    [Abstract] [Full Text] [Related]

  • 5. One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients.
    Gomi F, Ohji M, Sayanagi K, Sawa M, Sakaguchi H, Oshima Y, Ikuno Y, Tano Y.
    Ophthalmology; 2008 Jan 03; 115(1):141-6. PubMed ID: 17582498
    [Abstract] [Full Text] [Related]

  • 6. Choroidal thickness, vascular hyperpermeability, and complement factor H in age-related macular degeneration and polypoidal choroidal vasculopathy.
    Jirarattanasopa P, Ooto S, Nakata I, Tsujikawa A, Yamashiro K, Oishi A, Yoshimura N.
    Invest Ophthalmol Vis Sci; 2012 Jun 14; 53(7):3663-72. PubMed ID: 22570352
    [Abstract] [Full Text] [Related]

  • 7. Real-World Treatment Outcomes of Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy in Asians.
    Fenner BJ, Ting DSW, Tan ACS, Teo K, Chan CM, Mathur R, Yeo IYS, Wong TY, Wong EYM, Cheung CMG.
    Ophthalmol Retina; 2020 Apr 14; 4(4):403-414. PubMed ID: 31953109
    [Abstract] [Full Text] [Related]

  • 8. Combined reduced fluence photodynamic therapy and intravitreal ranibizumab for polypoidal choroidal vasculopathy.
    Ricci F, Calabrese A, Regine F, Missiroli F, Ciardella AP.
    Retina; 2012 Jul 14; 32(7):1280-8. PubMed ID: 22218148
    [Abstract] [Full Text] [Related]

  • 9. Photodynamic therapy combined with intravitreal injection of vascular endothelial growth factor antibody for polypoidal choroidal vasculopathy.
    Moon SW, Kim MS, Kim ES, Yu SY, Kwak HW.
    Ophthalmologica; 2011 Jul 14; 225(3):169-75. PubMed ID: 21273795
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Optic disk melanocytoma associated with polypoidal choroidal vasculopathy lesions, after combination treatment of photodynamic therapy and intavitreal aflibercept (Eylea), a case report.
    Rouvas A, Gouliopoulos NS, Moschos MM, Theodossiadis P.
    BMC Ophthalmol; 2018 Oct 12; 18(1):267. PubMed ID: 30309335
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Differentiating Exudative Macular Degeneration and Polypoidal Choroidal Vasculopathy Using OCT B-Scan.
    Kokame GT, Omizo JN, Kokame KA, Yamane ML.
    Ophthalmol Retina; 2021 Oct 12; 5(10):954-961. PubMed ID: 34022443
    [Abstract] [Full Text] [Related]

  • 14. Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration.
    Becerra EM, Morescalchi F, Gandolfo F, Danzi P, Nascimbeni G, Arcidiacono B, Semeraro F.
    Curr Drug Targets; 2011 Feb 12; 12(2):149-72. PubMed ID: 20887246
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness of polypoidal lesion-selective photodynamic therapy with intravitreal antivascular endothelial growth factor for polypoidal choroidal vasculopathy.
    Komuku Y, Iwahashi C, Gomi F.
    Jpn J Ophthalmol; 2020 May 12; 64(3):265-270. PubMed ID: 32206935
    [Abstract] [Full Text] [Related]

  • 16. Reduced-fluence photodynamic therapy combined with intravitreal bevacizumab for polypoidal choroidal vasculopathy.
    Sagong M, Lim S, Chang W.
    Am J Ophthalmol; 2012 May 12; 153(5):873-882.e2. PubMed ID: 22265146
    [Abstract] [Full Text] [Related]

  • 17. [Age-related Macular Degeneration in the Japanese].
    Yoshimura N.
    Nippon Ganka Gakkai Zasshi; 2016 Mar 12; 120(3):163-88; discussion 189. PubMed ID: 27164756
    [Abstract] [Full Text] [Related]

  • 18. Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration.
    Ladas ID, Kotsolis AI, Papakostas TD, Rouvas AA, Karagiannis DA, Vergados I.
    Retina; 2007 Sep 12; 27(7):891-6. PubMed ID: 17891013
    [Abstract] [Full Text] [Related]

  • 19. Refractory neovascular age-related macular degeneration secondary to polypoidal choroidal vasculopathy.
    Cho M, Barbazetto IA, Freund KB.
    Am J Ophthalmol; 2009 Jul 12; 148(1):70-8.e1. PubMed ID: 19403115
    [Abstract] [Full Text] [Related]

  • 20. Non-ICGA treatment criteria for Suboptimal Anti-VEGF Response for Polypoidal Choroidal Vasculopathy: APOIS PCV Workgroup Report 2.
    Chong Teo KY, Sadda SR, Gemmy Cheung CM, Chakravarthy U, Staurenghi G, Invernizzi A, Ogura Y, Ruamviboonsuk P, Chen SJ, Gupta V, Tan C, Chhablani J, Corvi F, Kim JE, Gomi F, Koh AH, Kokame G, Mitchell P, Wong TY, Lee WK, Lai TYY.
    Ophthalmol Retina; 2021 Oct 12; 5(10):945-953. PubMed ID: 33866022
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.